KCT0004861
Completed
未知
Dynamic Contrast Enhanced Magnetic Resonance Imaging Parameters after Radiotherapy for Bone Metastases in Patients with Hepatocellular Carcinoma : A Prospective Study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Sponsor
- Samsung Medical Center
- Enrollment
- 14
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with hepatocellular carcinoma who were scheduled to
- •undergo radiation therapy for bone metastases were included. Patients were
- •included in the study if they were aged older than 18 years, had been diagnosed
- •to have hepatocellular carcinoma either by histological evaluation or clinical
- •imaging, and have been diagnosed to have metastases in thoracic, lumbosacral
- •vertebra, pelvic bone, or proximal femur. The criteria for considering bone
- •metastasis from hepatocellular carcinoma includes newly developed lesions, clear
- •progression of the lesion revealed from the follow\-up examinations, or
- •histopathologic confirmation by bone biopsy if available.
Exclusion Criteria
- •Patients with history of another primary malignancy, history
- •of surgery, radiation therapy, or metallic instrumentation in thoracic,
- •lumbosacral spine, pelvic bone, or proximal femur, contraindication to
- •gadolinium\-based contrast agents or MRI examinations, female patients who are
- •pregnant or nursing.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study for Biochemocal Failures after Radical ProstatectomyProstate cancerJPRN-UMIN000009823The University of Tokyo Hospital50
Completed
Phase 2
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-alpha in patients with advanced renal cell carcinomaAdvanced or metastatic renal cell carcinomaCancerMalignant neoplasm of kidney, except renal pelvisISRCTN08193901East and North Hertfordshire NHS Trust (UK)30
Not yet recruiting
Not Applicable
Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) in predicting Chemoradiation Sensitive Nasopharyngeal Carcinoma and Plasma Epstein-Barr virus (EBV) levelasopharyngeal carcinomaDynamic contrast enhanced magnetic resonance imagingPerfusionNasopharyngeal carcinomaTCTR20180227002none40
Completed
Not Applicable
Contrast enhanced Magnetic Resonance Imaging of the lungs in children with Cystic Fibrosis.10038716mucoviscoidosisNL-OMON31207Erasmus MC, Universitair Medisch Centrum Rotterdam30
Active, not recruiting
Not Applicable
MRI in Diagnosing Solid Tumors of the Eye and OrbitEye CancerNCT01653080University of Cincinnati80